Barclays PLC — M&A Activity 2021

Mar 22, 2021

National Storage Mechanism | Additional information

Form 8.3 - WILLIS TOWERS WATSON PLC - Amendment

Ap19

FORM 8.3 - Amendment to purchase and sales

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

	Name of person dealing (Note 1)	Barclays PLC.
	Company dealt in	WILLIS TOWERS WATSON PLC
	Class of relevant security to which the	ORD
	dealings being disclosed relate (Note 2)
	Date of dealing	18 March 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security:		ORD
		Long		Short
		Number	(%)	Number	(%)
(1)	Relevant securities
		1,808,123	1.40%	184,235	0.14%
(2)	Derivatives (other than options):
		102,935	0.08%	7,066	0.01%
(3)	Options and agreements to
	purchase/sell:	6,100	0.00%	6,100	0.00%
	TOTAL:
		1,917,158	1.49%	197,401	0.15%

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:	Long			Short
	Number		(%)	Number		(%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale	Number of relevant securities	Price per unit
Purchase	1	221.1800 USD
Purchase	4	220.5850 USD
Purchase	4	221.2462 USD
Purchase	10	221.3700 USD
Purchase	14	220.9100 USD
Purchase	14	220.8946 USD
Purchase	16	222.7587 USD
Purchase	30	221.0383 USD
Purchase	50	221.2700 USD
Purchase	50	220.3300 USD
Purchase	100	221.1900 USD
Purchase	100	221.2550 USD
Purchase	100	221.6300 USD
Purchase	103	220.7736 USD
Purchase	129	221.3306 USD
Purchase	143	220.8302 USD
Purchase	197	221.0220 USD
Purchase	218	221.3697 USD
Purchase	319	220.9500 USD
Purchase	518	220.7987 USD
Purchase	600	220.8650 USD
Purchase	1,111	221.1592 USD
Purchase	2,361	220.9762 USD
Purchase	3,293	221.0187 USD
Purchase	6,649	220.9712 USD
Purchase	8,503	221.1400 USD
Purchase	8,690	221.0152 USD
Purchase	8,944	221.1661 USD
Purchase	11,485	221.1269 USD
Purchase	12,810	221.1839 USD
Purchase	12,966	221.0120 USD
Sale	1	221.1800 USD
Sale	1	221.6200 USD
Sale	52	221.0700 USD
Sale	87	221.4377 USD
Sale	90	221.1488 USD
Sale	99	221.3800 USD
Sale	100	220.8500 USD
Sale	100	220.9403 USD
Sale	100	221.1100 USD
Sale	100	221.2500 USD
Sale	102	221.3606 USD
Sale	110	221.2655 USD
Sale	167	221.2195 USD
Sale	200	220.8490 USD
Sale	200	221.0900 USD
Sale	201	221.2433 USD
Sale	257	221.0331 USD
Sale	267	221.3782 USD
Sale	300	220.4266 USD
Sale	300	221.2900 USD
Sale	419	221.2242 USD
Sale	480	220.9787 USD
Sale	599	221.2536 USD
Sale	623	221.1774 USD
Sale	889	221.2362 USD
Sale	989	221.1442 USD
Sale	1,337	221.2416 USD
Sale	1,344	220.9152 USD
Sale	1,637	221.1812 USD
Sale	2,161	220.9694 USD
Sale	3,362	221.1285 USD
Sale	3,442	221.1801 USD
Sale	3,462	221.0723 USD
Sale	4,155	220.9048 USD
Sale	4,535	221.1163 USD
Sale	6,405	221.1839 USD
Sale	10,923	221.0114 USD
Sale	14,149	221.0292 USD
Sale	15,141	221.1400 USD

(b) Derivatives transactions (other than options transactions)

Product name, e.g. CFD	Nature of transaction (Note 6)	Number of relevant securities (Note 7)	Price per unit (Note 5)

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name, e.g. call option	Writing, selling, purchasing, varying etc.	Number of securities to which the option relates (Note 7)	Exercise price	Type, e.g. American, European etc.	Expiry date	Option money paid/received per unit (Note 5)

(ii) Exercising

Product name, e.g. call option	Number of securities	Exercise price per unit (Note 5)

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction (Note 8)	Details	Price per unit (if applicable) (Note 5)

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached?	YES
Date of disclosure:	22 Mar 2021
Contact name:	Large Holdings Regulatory Operations
Telephone number:	020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection

Ap23

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name	Written or	Number of	Exercise	Type	Expiry
	purchased	relevant securities	price		date
		to which the option
		or derivative
		relates
Put Options	Purchased	-100	220.0000	American	Jul 16, 2021
Call Options	Purchased	100	240.0000	American	Jul 16, 2021
Call Options	Purchased	6,000	220.0000	American	Jul 16, 2021
Put Options	Purchased	-6,000	200.0000	American	Jul 16, 2021

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210322005621/en/

BARCLAYS PLC